TrackCore LLC v. Biomedical Synergies, Inc.
Infringement action filed 12 Sep 2025 in the United States District Court for the District of Minnesota and closed 18 May 2026, with 2 patents asserted. Recorded basis of termination: dismissed with prejudice.
Case record
- Patents involved
- US8666762B2US10671706B2
- Case no.
- 0:25-cv-03643
- Verdict cause
- Infringement action
- Court
- D. Minn.
- Court level
- District Court
- Case region
- Minnesota
- Chief judge
- None recorded
- Trial level
- First instance
- Filed – Closed
- 12 Sep 2025 – 18 May 2026
- Duration
- 248 days
- Basis of termination
- Dismissed with Prejudice
- Products & marks
- TRACS4Life – Tissue management and tracking software solution” that “uses manufacturers’ barcodes to track and trace human tissue products through a facility’s supply chain. · tissue tracking and implant tracking system
Check this patent against your own product
Prior art, claim scope, infringement exposure and design-around routes. Every answer cites the records behind it.
Get an FTO claim chart- 01Ranked prior artEvery hit source-linked
- 02Claim-level comparisonAgainst your own product
- 03Legal statusAcross 174 jurisdictions
Tissue management system
The present invention provides a comprehensive tissue management system for transplantable materials like tissues and organs. The tracking portion of the system prompts and verifies that staff members of a medical establishment like a hospital have handled, stored, transported, reconstituted, and used the tissue or organ materials in a safe and regulatory-compliant manner from the point of receipt to the point of issuance or surgical use throughout the hospital’s organization. The tracing portion of the system creates an integral record that documents which hospital staff members have provided which processing steps to the tissue or organ, any associated materials used in conjunction with such tissue or organ, and an identification of the tissue or organ that was transplanted or implanted inside a patient. Such a system will enable adverse reaction investigations for transplant patients, and recalls of transplantable materials.
- Legal status
- Active
- Granted
- 4 Mar 2014
- Earliest priority
- 21 Sep 2006
- Est. expiry
- 12 May 2030
- Validity challenges
- None recorded
- Licences recorded
- None recorded
- Inventors
- KASPRISIN, DUKE O · KOZLOSKI, PAUL E. · KOZLOSKI, SUSAN A. · VERCILLO, AGNES · WINSTEAD, JEFFREY K.
- Classification
- G06Q10/00G06Q50/00
- Prosecution counsel
- DeWitt LLP
- Examiner
- FUELLING, MICHAEL
Tissue management system
The present invention provides a comprehensive tissue management system for transplantable materials like tissues and organs. The tracking portion of the system prompts and verifies that staff members of a medical establishment like a hospital have handled, stored, transported, reconstituted, and used the tissue or organ materials in a safe and regulatory-compliant manner from the point of receipt to the point of issuance or surgical use throughout the hospital’s organization. The tracing portion of the system creates an integral record that documents which hospital staff members have provided which processing steps to the tissue or organ, any associated materials used in conjunction with such tissue or organ, and an identification of the tissue or organ that was transplanted or implanted inside a patient. Such a system will enable adverse reaction investigations for transplant patients, and recalls of transplantable materials.
- Legal status
- Active
- Granted
- 2 Jun 2020
- Earliest priority
- 21 Sep 2006
- Est. expiry
- 22 Feb 2030
- Validity challenges
- None recorded
- Licences recorded
- None recorded
- Inventors
- KASPRISIN, DUKE O · KOZLOSKI, PAUL E. · KOZLOSKI, SUSAN A. · VERCILLO, AGNES · WINSTEAD, JEFFREY K.
- Classification
- G16H40/20G06Q10/08G06Q50/22G16H20/40
- Prosecution counsel
- DeWitt LLP
- Examiner
- NAJARIAN, LENA
Parties of record
TrackCore LLC
- Core tech
- Not recorded
- Counsel
- Catherine Nyarady · David E. Cole · Ruth A Rivard
- Firm
- Paul, Weiss, Rifkind, Wharton & Garrison LLP, Stinson LLP
Biomedical Synergies, Inc.
- Core tech
- G06Q10/00G06Q50/00G16H40/20G06Q10/08
- Counsel
- David L. Biek · Elijah B. Van Camp · Eric Hugh Chadwick · Joseph Michael Graen
- Firm
- DeWitt LLP, DeWitt, LLP
Counsel of record
| Attorney | For | Role |
|---|---|---|
| Catherine Nyarady | TrackCore LLC | Plaintiff |
| David E. Cole | TrackCore LLC | Plaintiff |
| Ruth A Rivard | TrackCore LLC | Plaintiff |
| David L. Biek | Biomedical Synergies, Inc. | Defendant |
| Elijah B. Van Camp | Biomedical Synergies, Inc. | Defendant |
| Eric Hugh Chadwick | Biomedical Synergies, Inc. | Defendant |
| Joseph Michael Graen | Biomedical Synergies, Inc. | Defendant |
Basis of termination
From the record · verbatim“Pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii) and the terms of the parties’ Settlement Agreement dated May 12, 2026, Plaintiff TrackCore LLC and Defendant Biomedical Synergies, Inc., acting through their respective counsel, hereby stipulate to the dismissal with prejudice of this action, including all claims and counterclaims asserted by the parties herein, with each party bearing its own costs, attorney’s fees, and expenses and waiving any right to be deemed a “prevailing party” in this action. As set forth in the parties’ Settlement Agreement, this Court shall maintain jurisdiction over the parties with respect to any disputes related to that Agreement.”
Case 0:25-cv-03643 · D. Minn. · closed 18 May 2026
Related cases
Three questions this record usually leads to. Each one runs against the full litigation and patent corpus, and cites what it finds.
Frequently asked questions
What is case 0:25-cv-03643?
0:25-cv-03643 is a patent infringement action brought by TrackCore LLC against Biomedical Synergies, Inc., filed on 12 Sep 2025 in the United States District Court for the District of Minnesota. The case closed on 18 May 2026.
Which patents were asserted in 0:25-cv-03643?
US8666762B2 (“Tissue management system”), assigned to BIOMEDICAL SYNERGIES, INC., currently active; US10671706B2 (“Tissue management system”), assigned to BIOMEDICAL SYNERGIES, INC., currently active. The record also lists TRACS4Life – Tissue management and tracking software solution” that “uses manufacturers’ barcodes to track and trace human tissue products through a facility’s supply chain. and tissue tracking and implant tracking system.
How was case 0:25-cv-03643 terminated?
The recorded basis of termination is dismissed with prejudice. The termination text reads: “Pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii) and the terms of the parties’ Settlement Agreement dated May 12, 2026, Plaintiff TrackCore LLC and Defendant Biomedical Synergies, Inc., acting through their respective counsel, hereby stipulate to the dismissal with prejudice of this action, including all claims and counterclaims asserted by the parties herein, with each party bearing its own costs, attorney’s fees, and expenses and waiving any right to be deemed a “prevailing party” in this action. As set forth in the parties’ Settlement Agreement, this Court shall maintain jurisdi
What does dismissal with prejudice mean?
A dismissal with prejudice permanently ends the claims that were filed, so the same claims cannot be brought again against that defendant. It is the usual form when the parties have settled.
How long did case 0:25-cv-03643 take?
248 calendar days, from filing on 12 Sep 2025 to closure on 18 May 2026.
Who were the attorneys and the judge in 0:25-cv-03643?
Catherine Nyarady, David E. Cole and Ruth A Rivard are recorded as counsel for plaintiff TrackCore. David L. Biek, Elijah B. Van Camp, Eric Hugh Chadwick and Joseph Michael Graen appear for defendant Biomedical Synergies.
Disclaimer. This page reproduces publicly available court docket data for case 0:25-cv-03643 and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Docket data has limits. Records are drawn from a snapshot and may lag the live docket. Sealed filings, amended complaints, counterclaims and post-closure motions may not be reflected. Party names, attorney names and firm affiliations are reproduced as recorded and may contain omissions. Where a field is absent from the record, this page marks it as not recorded rather than inferring a value.
No characterisation of the parties or the outcome. This page reports what the record contains. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, that any settlement occurred, or that any party prevailed.
No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.